A B S T R A C T
INTRODUCTION
Rapidly accumulating evidence indicates that infarct size is an important determinant of morbidity and mortality after acute myocardial infarction (1) (2) (3) (4) analysis of myocardial damage based on morphology alone is not readily applicable to patients. To quantify the extent of ischemic injury in conscious animals and in patients, we have previously utilized mathematical analysis of serial serum CPK changes (8) . However, since this approach detects damage only after the fact, it cannot be used to predict the ultimate extent of the completed infarct during its early evolution.
In the present study, we have applied curve-fitting techniques to analysis of serial serum CPK changes in conscious dogs with coronary occlusion and in patients with spontaneous myocardial infarction in order to predict the extent of infarction. Anticipated serum CPK values were projected on the basis of changes occurring soon after the onset of ischemia; infarct size2 was predicted from the projected values; predicted "infarct size" was compared with observed "infarct size" and the extent of myocardial salvage after physiological and pharmacological interventions was qiuantified.
METHODS

Experimental studies
Coronary occlusion was produced in 37 conscious dogs by constriction of an externalized snare placed around a branch of the left anterior descending coronary artery 1 wk earlier as previously described (8) . CPK activity was measured serially for 24 h in serum samples obtained through an inlying jugular venous catheter at 60-90-min intervals after coronary occlusion. "Infarct size" was calculated from serum CPK changes (ISs) and compared with "infarct size" predicted (ISp) from CPK curves projected on the basis of early data points (see analysis of data). The animals were then killed and the extent of ischemic injury was measured directly by determination of myocardial CPK depletion (8, 9) .
In selected animals, the extent of infarction was modified during its evolution by either the administration of isoproterenol in peanut oil (0.15 mg/kg, s.c.) beginning 14 h after coronary occlusion and repeated 3 h later or by the administration of propranolol (2 mg/kg, i.v.) beginning 5 h after occlusion and continued at a dose sufficient to maintain heart rate at less than 85 beats/min compared with the average heart rate of 100 beats/min in animals with coronary occlusion alone.
Clinical studies
Serum CPK activity was determined in serial samples obtained every 1 aminase, lactate dehydrogenase, and CPK); and evolution of electrocardiographic changes including Q waves diagnostic of transmural myocardial infarction. In each case infarct size was estimated from serum CPK changes as previously described. In all patients with initially normal serum CPK values (<40 ml U/ml), infarct size was predicted from changes occurring within 7 h after the initial serum CPK elevation (see analysis of data section).
Biochemical procedures
CPK activity was determined in dog serum, dog myocardial homogenates, and human serum by a spectrophotometric kinetic method as previously described (8, 9) . Protein was measured by the biuret procedure (10) .
Analysis of data
A. Determination of infarct size by analysis of myocardial CPK content. Myocardial CPK depletion was determined by analysis of CPK concentration in normal myocardium and total left ventricular CPK content in each animal as well as measurement of left ventricular weight. We have previously demonstrated that the extent of myocardial CPK depletion after sustained or interrupted coronary occlusion correlates with infarct size assessed morphologically (9, 11, 12) . Accordingly, in the present study, infarct size was determined from myocardial CPK depletion as previously described (8) .
B. Determination of infarct size by analysis of serial serum CPK changes. After myocardial infarction the rate of change of enzyme activity in serum (dE/dt) depends on at least two competing phenomena: release of enzyme from the heart (f(t)) and clearance of enzyme from the blood (kdE) (8) . Thus, dE/dt = f(t) + kdE. We have shown previously that the cumulated amount of CPK released from the heart (CPKr) appearing in 1 ml of serum can be calculated from f f (t)dt(IU/ml). The value of this expression is proportional to the amount of CPK released from the heart. Its magnitude reaches the same ultimate value whether the rate of release of CPK from the heart is slow or rapid as long as the total amount of CPK released is the same. Since the fractional disappearance rate of serum CPK activity can be approximated by a constant, kd, which has been measured experimentally (8) (8, 14) . In the dog, the proportion of CPK depleted from myocardium appearing in the serum (D) is virtually constant (8, (12) (13) (14) (15) The integral is evaluated to a point in time (T) chosen to coincide with the time at which enzyme release is zero assuming a monoexponential decay (kd). The log-normal equation approaches zero as t approaches infinity but not monoexponentially. However, over the interval of experimental and clinical interest, the rate of decay described by the log-normal function [(d4 -c + lnt)/d4t] closely approximates kd. After the point in time when the decay described by the log-normal function deviates from kd, the contribution of kdE to infarct size is too small to change the calculated value for infarct size appreciably because E is approaching zero.
The curve-fitting technique described permits prediction of infarct size on the basis of early observed serum CPK changes. Naturally, the correlation between infarct size predicted by application of this method and observed infarct size can be ascertained only by actual exl)erimental observations.
RESULTS
The correlation between infarct size estimated from best fit serum CPK curves and infarct size calculated from observed serum CPK changes in the conscious dog. Serial serum CPK changes after myocardial infarction in a representative conscious dog are illustrated in Fig.  1A . Fig. 1B depicts a representative example of a CPK curve obtained by curve fitting all actual serum CPK data in the same animal. As can be seen, the curve depicting observed values and the best fit curve derived from observed values are almost identical. Infarct size calculated from the observed data was 25.6 CPK-g-eq3 compared with 25.7 estimated from the best fit curve. Thus, in this example the actual CPK curve is closely approximated by the best fit curve conforming to a log-normal distribution.
XVhen successively fewer real data points are used as the basis for obtaining the best fit curve, predicted infarct size can be estimated from the CPK values 31 CPK-gram-equivalent (CPK-g-eq) is that quantity of myocardium undergoing necrosis exhibiting total CPK depletion equivalent to depletion in 1 g of tissue undergoing homogeneous necrosis in the center of an infarct. size and actual infarct size was close when data for at least the first 300 min were utilized as the basis for CPK curve fits. In addition, as can be seen in Table I, the overall standard error remained small in curves fit from initial data as long as data from at least 300 min after coronary occlusion were used as the basis for curve fitting.
To examine the relationship between infarct size predicted from early serum CPK changes and infarct size calculated from observed serum CPK changes during the first 24 h predictions were made in 11 conscious dogs 300 min after coronary occlusion (IS:300) and compared with infarct size calculated from: (a) 24 h serial CPK analysis (ISs) and (b) direct measurement of myocardial CPK depletion. Results are shown in Table II . As can be seen IS300 corresponded closely to ISs and to infarct size measured directly. Close correlations were seen over a wide range of infarct size. The mean difference between infarct size measured directly and IS300 was 1.8 CPK-g-eq-+0.4 and the mean difference between ISs and IS300 was 4.541.5. These represent mean percent differences of 642 and 1443%, respectively. We have previously shown that ISs correlates closely with infarct size measured directly (8) . As shown in Fig. 2A , the correlation between infarct size calculated from the best fit curve derived from 24 h serum CPK changes and infarct size measured directly was also close (r = 0.98, n = 11).
Furthermore, when infarct size was estimated from CPK curves fit from enzyme changes during the first In eight other dogs, propranolol was administered beginning 5 h after coronary occlusion when infarct size had already been predicted. The animals were killed 24 h after coronary occlusion and infarct size was verified by determination of myocardial CPK content. As shown in the representative experiment illustrated in Fig. 4 , serum CPK values fell below the confidence limits of the projected CPK curve within 4 h after administration of propranolol commenced. In this example predicted infarct size was 47 CPK-g-eq, ISs was 32 CPK-g-eq, and infarct size measured from myocardial CPK analysis was 35 CPK-g-eq. Thus, propranolol resulted in salvage of 32% of the anticipated infarct. The ratio between CPK activity lost from myocardium and that accounted for in serum remained constant (0. (8) SIGURE 8 (A) Changes in observed serum CPK activity after spontaneous extension of infarction compared with values for serum CPK changes obtained from the best fit curve derived from early data. The initial bout of chest pain occurred 4 h before zero time, defined as the last time when serum CPK activity was within the normal range. Predicted infarct size was calculated from the best fit log-normal function based on serial serum CPK changes during the first 7 h after zero time. Recurrence of pain occurred 12 h after zero time and was associated with ST segment elevation on the electrocardiogram. Within 2 h observed serum CPK values deviated from those on the best fit curve derived from early data. (B) Changes in serum CPK activity after administration of trimethaphan compared with values for serum CPK activity conforming to the best fit log-normal function derived from early data. The initial episode of chest pain occurred 6 h before zero time. Predicted infarct size was calculated from the best fit curve derived from data obtained during the first 7 h after zero time. Administration of trimethaphan (500 mg/liter) was initiated to lower systolic blood pressure by 25 mm Hg. CPK activity fell below the 95% confidence limits of the best fit curve within a short time. During the latter portion of the observation period serum CPK values declined in parallel with the terminal portion of the best fit curve. Infarct size predicted from the log-normal function based on data before the intervention was 52.8 compared with the calculated value of 27.2 CPK-g-eq for the completed infarct based on analysis of all observed serum CPK changes.
ug/kg/min). As can be seen in the example depicted in Fig. 8B , observed serum CPK activity declined below the 95% confidence limits of projected values within 2 h after the onset of antihypertensive therapy. In this example, infarct size predicted on the basis of the CPK curve fit from data during the initial 7 h was 52.8 CPK-g-eq and infarct size calculated from observed serum CPK values through the time when antihypertensive therapy was discontinued was 27.2 CPK-g-eq.
Thus, predicted infarct size was reduced by 49%. A similar result has been obtained in 9 of 11 patients evaluated and treated with this approach. Clearly, conclusions regarding the long-term benefit of such therapeutic interventions depend on analysis of many patients and on long-term follow-up. These results are presented only demonstrate that comparison of observed to predicted infarct size appears to be one useful means for evaluating potentially favorable therapeutic interventions in patients with acute myocardial infarction.
DISCUSSION
Results in this study demonstrate that infarct size can be predicted from serial serum CPK changes occurring during early evolution of infarction by means of nonlinear least squares curve-fitting techniques in the conscious dog subjected to coronary artery occlusion and in patients with spontaneous myocardial infarction.
Since infarct size appears to be a major determinant of prognosis (1) (2) (3) (4) kd and the value of this ratio are virtually identical.
Beyond this range, kd deviates from the value of the ratio. However, the term kdE approaches zero since E is near zero. Thus, estimation of infarct size is not affected appreciably by the deviation of kd from the ratio.
Observations in the clinical studies were analogous to those in the studies performed with conscious dogs. In 30 patients with uncomplicated acute myocardial infarction, best fit log-normal curves based on all available serum CPPK values closely approximated observed curves. Thus, in patients with acute myocardial infarction, as in conscious dogs with coronary artery occlusion, serum CPK curves conform closely to best fit log-normal functions. In addition, in these 30 patients, infarct size predicted from best fit curves based on serum CPK data obtained only during the first 7 h correlated closely with infarct size calculated from all available serum values (r = 0.93). The mean difference between predicted and observed infarct size was only 4%. In the present study, predictions of infarct size were obtained only in patients with normal serum CPK values at the time of admission.
Application of nonlinear curve-fitting techniques to predict serum enzyme values and predictions of infarct size by this method require considerable caution. Nonlinear systems do not necessarily exhibit unique solutions. Moreover, the methods used to produce the least squares fit may result in convergence to biologically meaningless minima if initial estimates for parameters are inappropriate. The computer program used in these studies employed the Gauss-Newton approach to a least squares solution and applied standard linear techniques; an approach that assumes linearity of the normal equations over short ranges. It became clear early in these studies that the three (b,c,d) nonlinear parameters in the log-normal equation were related to aspects of the distribution of CPK activity as a function of time. Thus, b appeared to reflect both the time to peak CPK activity and the magnitude of peak activity; c to the natural logarithm of the time to peak activity, and d to the width (or standard deviation) of the distribution. Since In this study kd is assumed to be constant-an assumption requiring qualification. \We have approximated the clearance of enzyme as a single exponential characterized by a constant fractional disappearance rate (kd) since activity of partially purified dog heart CPK injected intravenously decays in a manner approximating that predicted by a monoexponential function (8) . However, a priori, the actual disappearance of CPK released from the heart cannot be monoexponential since it is known that different isoenzymes of CPK disappear from serum at different rates and that myocardium contains more than one CPK isoenzyme. Thus kd in the present formulation is an approximation. On the basis of experiments performed in conscious dogs, the average value of kd was 0.0045 ±0.001 min-(mean ±SD, t = 11) (8). In patients, the value for kd was approximated by measuring the decline of CPK activity during the terminal portion of CPK curves when release of enzyme from myocardium could be assumed to have ceased (kd was found to average 0.00140.0005 min1, n = 24) (1). In calculations of infarct size in patients, we elected to use this mean value for kd although it entails a potential variation of infarct size from patient to patient of ±30% (with kd varying by 1 SD). Evidence obtained in conscious dogs indicates that kd remains essentially constant despite hemodynamic perturbations or impairments in hepatic or renal function (8, 14) . The relative uniformity of kd among patients requires verification. kd could be measured by injection of CPK in patients and assay of disappearance of its activity or estimated by approximation from the best fit log-normal function from the term: dI/dtmax = ed4-(1+c)/d4. However Interventions which slow the evolution of necrosis will not necessarily result in overall salvage of myocardium subsequently. Nevertheless, at any given time after the onset of an ischemic insult, the extent of damage which has already occurred can be assessed by the method proposed. Estimation of infarct size from analysis of serial serum CPK changes is based on the concept that myocardial CPK depletion is related quantitatively to the extent of myocardial necrosis. Enzyme release from myocardium into serum has been observed to be associated with irreversible injury by others (19) (20) (21) (22) (23) (24) (25) (26) . The magnitude of myocardial CPK depletion has been correlated with the extent of ischemic injury assessed electrocardiographically (5, 11) , sustained decrease in regional blood flow (9) , abnormalities in function of mitochondria isolated from the heart (27), prevalence of histologic changes indicative of necrosis (11) , and the magnitude of functional impairment (11) . Mlyocardial CPK depletion after sustained coronary occlusion appears to be directly related to infarct size estimated as a proportion of the left ventricle in animals of similar body weight measured grossly (9, 12) .
Trhus, it appears that myocardial C(PK depletion is a (luantitative index of the extent of necrosis after sustained coronary artery occlusion.
Our results indicate that serial serum CPK changes after acute myocardial infarction conform closely to a log-normal function which can be defined within 7 h of the onset of initial serum CPK elevations in patients, and that extension of infarction and salvage of jeopardiz d myocardium can be recognized and quantified by comparison of observed to predicted infarct size. The approach described is of potential value in the assessment of therapeutic interventions designed to modify infarct size favorably in patients with acute myocardial infarction and in appropriate selection of patients for potentially therapeutic procedures with significant attendant risks.
